Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market

Cyclerion Therapeutics Cash flow

144 Followers

Cyclerion Therapeutics Cash Flow

CYCN's free cash flow for Q3 2022 was $-9.91M. For the 2022 fiscal year, CYCN's free cash flow was decreased by $37.49M and operating cash flow was $-9.91M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -42.20M$ -36.52M$ -72.49M$ -102.22M$ -97.50M$ -81.22M
Investing Cash Flow
-$ 1.46M$ 18.00K$ -6.71M$ -3.44M$ -1.40M
Financing Cash Flow
$ 102.00K$ 30.79M$ 28.09M$ 211.57M$ 100.94M$ 82.62M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 145.81M$ 53.96M$ 58.23M$ 102.62M$ 0.00$ 0.00
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-$ 30.50M$ 24.25M$ 175.00M$ 0.00-
Issuance Of Debt
-$ 0.00$ 3.51M$ 0.00--
Repayment Of Debt
------
Free Cash Flow
$ -42.20M$ -36.52M$ -74.01M$ -109.10M$ -100.94M$ -82.62M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cyclerion Therapeutics Cash Flow


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis